Targeting T cell killing with complement component C3-anti CD3 fusion proteins

Saved in:
Bibliographic Details
Published inTransplantation proceedings Vol. 30; no. 5; pp. 2351 - 2352
Main Authors Fecke, W, Koukidou, M, Farries, T.C, Harrison, R.A
Format Journal Article Conference Proceeding
LanguageEnglish
Published New York, NY Elsevier Inc 01.08.1998
Elsevier Science
Subjects
Animals
Biological and medical sciences
CD3 Complex - immunology
Cell Line
Complement C3 - pharmacology
COS Cells
Cytotoxicity, Immunologic
Humans
Immunoglobulin Fragments - pharmacology
Immunoglobulin Heavy Chains - pharmacology
Immunoglobulin Light Chains - pharmacology
Immunoglobulin Variable Region - pharmacology
Immunomodulators
Jurkat Cells
Medical sciences
Pharmacology. Drug treatments
Recombinant Fusion Proteins - pharmacology
T-Lymphocytes - immunology
Transfection
Target
Antibody
Cell death
Complement C3
T-Lymphocyte
Cytotoxicity
Cellular immunity
Fusion protein
Online AccessGet full text

Cover

More Information
ISSN:0041-1345
1873-2623
DOI:10.1016/S0041-1345(98)00649-6